This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) shed 2.53% to $258.20 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.02% to 49,015.60 and the S&amp;P 500 Index  falling 0.01% to 6,978.03.
This was the stock's fifth consecutive day of losses.
Insulet Corp. closed 27.24% below its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Eli Lilly &amp; Co. (LLY) fell 1.51% to $1,023.80, DexCom Inc. (DXCM) fell 0.42% to $73.36, and Johnson &amp; Johnson (JNJ) rose 1.46% to $227.72.
Trading volume (1.3 M) eclipsed its 50-day average volume of 770,920.
Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-28-26 1708ET

<p>Insulet Corp. (PODD) shares fell 2.53% to $258.20 on Wednesday, marking the fifth consecutive day of losses. The stock is currently 27.24% below its 52-week high of $354.88. In comparison, competitors Eli Lilly & Co. (LLY) and DexCom Inc. (DXCM) also saw declines, while Johnson & Johnson (JNJ) rose 1.46%. The overall market showed mixed results, with the Dow Jones up 0.02% and the S&P 500 down 0.01%. Trading volume for Insulet was 1.3 million, surpassing its 50-day average of 770,920.</p>

- Shares of Insulet Corp. (PODD) fell by 2.53% to $258.20, marking the fifth consecutive day of losses amid a mixed stock market.  
- The stock closed 27.24% below its 52-week high of $354.88, reached on November 20th, and underperformed compared to competitors like Eli Lilly and Johnson & Johnson.  
- Trading volume for Insulet was 1.3 million, surpassing the 50-day average volume of 770,920 shares.

Dow Jones

Defiance Daily Target 2X Long LLY ETF

DexCom

Invesco QQQ Trust

ALPS Medical Breakthrough

Insulet

VG Health

VG Growth

Proshares Ultra Nasdaq Biotech

Direxion Daily LLY Bull 2X Shares

iShares US Pharma

Johnson & Johnson

iShares Global Healthcare

iShares Biotechnology ETF

ISHRS Russ 1000 Growth

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Ark Genomic Revolution ETF

VG Mga Cap 300 Grw

Health Care Select Sector SPDR

SPDR S&P Health Equip

Schw Us L-Cp Grw

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

Eli Lilly

iShares Core S&P US Growth

iShares US Medical Devices

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors